STD Reimbursement Scenario Analysis and Top STD Testing Technologies - Global Opportunity Analysis and Industry Forecast, 2014 - 2022 - Product Image

STD Reimbursement Scenario Analysis and Top STD Testing Technologies - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

  • ID: 4033338
  • Report
  • Region: Global
  • 32 pages
  • Allied Analytics LLP
1 of 4
STD Reimbursement Scenario Analysis And Top STD Testing Technologies (Pcr, Immunochromatographic Capillary Flow Dipstick Technology, Flow Cytometry, Differential Light Scattering, Enzyme Linked Immunosorbent Assay, Rapid Diagnostic Kits, Phone Chips, Microfluidics, And Immunochromatographic Tests) - Global Opportunity Analysis And Industry Forecast, 2014 - 2022

The market revenue for diagnostic testing of STDs was valued at $107,024 million in 2015, and is projected to reach $190,010 million by 2022, registering a CAGR of 8.5% over the forecast period. Sexually transmitted diseases (STDs) are alternatively known as venereal diseases (VDs) or sexually transmitted infections (STIs). A variety of methods have been employed for diagnosis of STDs, which differ, based on the type of disease. Rising incidence of fatal STDs, increasing implementation of service provider-initiated counseling and testing (PICT) and client-initiated counseling and testing (CICT) and development of novel technologies such as microfluidics and rapid diagnostics kits for the test of HIV at home and collectively drive the growth of STD testing market. However, inadequate infrastructure provisions (such as laboratories, equipment, and consumables for the diagnostic tests), lack of trained laboratory personnel in the geographic locations (for example, West African countries) and stigma associated with voluntary testing can be the major restraints for the market. Nevertheless, global initiatives along with development in healthcare infrastructure will provide platform for the market growth.

Based on technology the market is divided into PCR, immunochromatographic capillary flow dipstick technology, flow cytometery, differential light scattering, enzyme linked immunosorbent assay, rapid diagnostic kits, phone chips, microfluidics, and immunochromatographic tests. The global STD diagnostics testing market is segmented based on the technology used for the disease diagnosis. It covers the revenue associated with the devices, consumables, disposables and the service cost involved in performing the procedure. PCR dominated the world STD testing market BY TECHNOLOGY in 2015 and it is expected to maintain the trend throughout the study period owing to its use as the final confirmatory test in most of the STDs. Based on location of testing, market is segmented into laboratories and point-of-care (POC). Currently, laboratories perform bulk of the tests and would continue to hold larger share of the market, both in terms of volume and revenue. Microfluidics is expected to be the fastest growing segment throughout the study period growing at a CAGR of 34.2% owing to the ease of use, technological advancements, and quick results.

KEY BENEFITS:

In-depth within all the technologies that would provide a clear understanding of current and future trends in the continuous glucose monitoring systems market.
Comprehensive analysis of reimbursement scenario that drive and restrict the growth of the continuous glucose monitoring systems market is provided.
The report covers detailed quantitative analysis of the current market, and estimations through 2014‐2022, which would enable the stakeholders to capitalize on prevailing market opportunities
An in-depth analysis of current reimbursement scenario within CGM System market is provided with key market dynamic factors that help in understanding the behaviour of market

KEY MARKET SEGMENTS

MARKET BY TESTING DEVICES

Laboratory Devices:
PCR
Immunochromatographic Capillary Flow Dipstick Technology
Flow Cytometers
Differential Light Scattering Machines
Enzyme Linked Immunosorbent Assay (ELISA)
POC Testing Devices:
Phone Chips
Microfluidics
Rapid Diagnostic Kits
Immunochromatographic Tests
READ MORE
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1. INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY MARKET SEGMENTS
1.3. RESEARCH METHODOLOGY
1.3.1. Secondary research
1.3.2. Primary research
1.3.3. Analyst tools and models

CHAPTER 2. EXECUTIVE SUMMARY

CHAPTER 3. REIMBURSEMENT SCENARIO
3.1. OVERVIEW
3.2. PREVENTIVE SERVICE BILLING AND CODING REFERENCE

CHAPTER 4. GLOBAL STD Testing MARKET, BY TECHNOLOGY
4.1. INTRODUCTION
4.1.1. Market size and forecast
4.2. LABORATORY TESTING DEVICES
4.2.1. Polymerase chain reaction (PCR)
4.2.1.1. Market size and forecast
4.2.2. Immunochromatographic capillary flow dipstick technology (Assay)
4.2.2.1. Market size and forecast
4.2.3. Flow cytometry
4.2.3.1. Market size and forecast
4.2.4. Differential light scattering
4.2.4.1. Market size and forecast
4.2.5. Enzyme linked immunosorbent assay (ELISA)
4.2.5.1. Market size and forecast
4.3. POINT-OF-CARE (POC) TESTING DEVICES
4.3.1. Phone Chips
4.3.1.1. Market size and forecast
4.3.2. Microfluidics
4.3.2.1. Market size and forecast
4.3.3. Immunochromatographic tests (ICTs)
4.3.3.1. Market size and forecast
4.3.4. Rapid diagnostic kits
4.3.4.1. Market size and forecast

List Of Tables

Table 1. STD Preventive Services By Cdc
Table 2. List of HCPCs/CPT Codes And Icd-10 Diagnosis Code
Table 3. Global STD Testing Market, By Location Of Testing, 2014-2022 ($Million)
Table 4. Global STD Testing Market, By Technology, 2014-2022 ($Million)
Table 5. World STD Testing Market For Pcr, 2014-2022 ($Million)
Table 6. World STD Testing Market For Immunochromatographic Capillary Flow Dipstick, 2014-2022 ($Million)
Table 7. World STD Testing Market For Flow Cytometry, 2014-2022 ($Million)
Table 8. World STD Testing Market For Differential Light Scattering, 2014-2022 ($Million)
Table 9. World STD Testing Market For Elisa, 2014-2022 ($Million)
Table 10. Testing Technologies For STDs
Table 11. World STD Testing Market For Phone Chips, 2014-2022 ($Million)
Table 12. World STD Testing Market For Microfluidics, 2014-2022 ($Million)
Table 13. World STD Testing Market For Immunochromatographic Test, 2014-2022 ($Million)
Table 14. Serological Test For STDs
Table 15. World STD Testing Market For Rapid Diagnostic Kits, 2014-2022 ($Million)

List Of Figures

Figure 1. World STD Testing Market For Pcr, 2014-2022 ($Million)
Figure 2. World STD Testing Market For Immunochromatographic Capillary Flow Dipstick, 2014-2022 ($Million)
Figure 3. World STD Testing Market For Immunochromatographic Capillary Flow Dipstick, 2014-2022 ($Million)
Figure 4. World STD Testing Market For Differential Light Scattering, 2014-2022 ($Million)
Figure 5. World STD Testing Market For Elisa, 2014-2022 ($Million)
Figure 6. World STD Testing Market For Phone Chips, 2014-2022 ($Million)
Figure 7. World STD Testing Market For Microfluidics, 2014-2022 ($Million)
Figure 8. World STD Testing Market For Immunochromatographic Test, 2014-2022 ($Million)
Figure 9. World STD Testing Market For Rapid Diagnostic Kits, 2014-2022 ($Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
A new report titled, STD Reimbursement Scenario Analysis and Top STD Testing Technologies - Global Opportunity Analysis and Industry Forecast, 2014 - 2022, projects that the global STD testing market was valued at $107,024 million in 2015, and is estimated to reach $190,010 million by 2022, registering a CAGR of 8.5% over the forecast period. Polymerase chain reaction (PCR) segment dominated the overall market with a share of more than half of the overall market in 2015, and is expected to continue to lead, owing to effective detection offered by this technology and high prevalence of sexually transmitted diseases.

High incidences of sexually transmitted diseases and increased governmental support are the factors that drive the market growth. In addition, favorable reimbursement scenario for STD tests, rise in awareness among people, and patient education are the other pivotal factors that fuel the growth of the market. However, stigma related to voluntary testing and stringent regulatory policies are the major restraints for the market growth. However, global initiatives along with development in healthcare infrastructure are projected to provide platform for the market growth.

Currently, laboratory testing devices accounted for the major share of the total market in 2015, as laboratories perform bulk of the tests. Microfluidics is expected grow fastest, growing at a CAGR of 34.2% owing to the ease of use, technological advancements, and quick results. Moreover, it provides excellent performance in the diagnosis of infectious diseases using only 1l of unprocessed whole blood in much less time.

Key findings of the study:
Polymerase chain reaction segment accounted for more than half of the total market in 2015.
Microfluidics is expected grow the fastest throughout the study period.
Laboratory testing devices accounted for the major share of the total market in 2015, as laboratories perform bulk of the tests.
Point-of-care testing devices segment is poised to grow at a CAGR of 10.1%.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll